Skip to main content
BIONEERCORPORATION logo

BIONEERCORPORATION — Investor Relations & Filings

Ticker · 064550 ISIN · KR7064550007 KO Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2020-09-18 Major Shareholding Noti…
Country KR South Korea
Listing KO 064550

About BIONEERCORPORATION

https://eng.bioneer.com/

Bioneer Corporation is a biotechnology company that develops and manufactures molecular biology products, technologies, and services for the life science research and molecular diagnostics markets. The company's portfolio includes a range of instruments, such as conventional and real-time PCR systems, and patented auxiliary devices for sample preparation. Bioneer provides integrated solutions for molecular diagnostics, offering kits for various infectious diseases. Additionally, it offers custom services including oligo and gene synthesis. The company's research and development efforts also focus on siRNA technologies and drug delivery systems.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (specifically the CEO and related parties). This type of filing is used to notify the market of significant changes in share ownership and is classified under 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-09-18 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) by Bioneer. It details the contract amount, the counterparty (High Standard Medical Inc.), the nature of the supply (medical equipment for COVID-19), and the contract duration. Since this is a specific regulatory announcement of a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-08-24 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company Bioneer (바이오니아) for the period ending 2020.06.30. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which fits the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by an executive (Hyena Kie) of Bioneer Corporation. This type of filing is a standard regulatory requirement for insiders to disclose their personal trading activities in the company's stock, which corresponds to the 'Director's Dealing' category.
2020-07-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a standard Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This document details the acquisition of shares by an executive (Lee Joong-yeol) of Bioneer Corporation. In the context of financial reporting, filings regarding personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2020-07-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal share transactions (insider trading). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2020-07-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.